REalloys: Operations Accelerating — Tactical Long While Execution Remains Key

Hook & thesis

REalloys is moving from concept to commercial operations faster than many expected. Two recent events - the closing of a roughly $100 million private placement on 06/26/2026 and conditional selection by the U.S. Army to design, finance, build and operate heavy rare-earth processing at Tooele Army Depot (announcement 06/25/2026) - materially change the risk/reward for the stock. Those items reduce near-term funding risk and create a tangible path to revenue for heavy rare-earth metals that are in acute defense demand.

That doesn’t mean the company is without risk — it remains pre-revenue, carries a high valuation multiple on non-existent sales and needs to execute technically complex projects. Still, the market is underpricing the optionality of near-term project starts and secured supply lines for dysprosium/terbium ahead of the January 1, 2027 federal procurement deadline. I’m bullish tactically: enter at $14.66, stop at $12.50, target $22.00, with a swing horizon tied to the next set of operational milestones.

What REalloys does and why the market should care

REalloys is building a vertically integrated North American rare-earth platform: recycling, mining, oxide production, metallization, alloying and magnet manufacturing. The company is positioning itself as a Western supplier for both light and heavy rare-earth metals and magnets - a strategic position given that China controls the bulk of current global production.

The market cares because the U.S. defense establishment has a hard deadline (January 1, 2027) to stop procuring Chinese-origin rare-earth materials. That creates an immediate, high-value demand window for compliant suppliers of dysprosium and terbium. REalloys has been active on three fronts that matter: capital (private placement closed 06/26/2026), strategic partnerships (15-year offtake for 15% of Tanbreez production and $20.6M investment in Saskatchewan Research Council upgrades), and the conditional Army selection to operate Tooele (06/25/2026). Together these items create a plausible commercial path into 2027.

Key numbers to anchor the thesis

• Market capitalization: roughly $897M (snapshot value ~ $897,389,910).
• Enterprise value: $856,681,151.
• Shares outstanding: ~61.21M; float roughly 56.27M.
• Recent financing: 7,017,540 shares at $14.25 announced and closed 06/26/2026 for gross proceeds of about $100M.
• Balance-sheet indicators: current ratio ~4.36 and cash metric shown at 2.92 (per-share style metric in reporting); debt-to-equity ~0.01 (very low leverage).
• Profitability: EPS is negative (-$1.80), ROA -84.56% and ROE -108.61% — this is a pre-revenue, build-out story.
• Trading metrics: 52-week range $5.52 - $26.90; current price ~ $14.66 (intraday high $15.3993, low $13.64 on the most recent session). Average volumes have expanded (2-week average ~4.15M), and recent daily volume reached ~10.5M on a run day.
• Short interest has been rising: most recent settlement 06/15/2026 at 3,240,830 shares short, with days-to-cover around 1 day. Short-volume on 06/26/2026 showed about 1,040,746 shares shorted out of total volume ~1,505,886 (roughly 69% of that day’s volume).

Valuation framing

On a traditional earnings basis the stock is not comparable: EPS -$1.80 and price/earnings is negative. Price-to-book runs ~8.85x and price-to-sales is extremely high because sales are not yet material. Enterprise value to sales and EV/EBITDA are likewise distorted (EV ~$856.7M; EV/EBITDA negative). In short, REalloys is being valued on future operations and strategic importance rather than current cash flows.

That’s reasonable for a strategic materials play if and only if the company executes. The recent $100M raise materially improves the runway to build processing capacity and meet early Army requirements. Market participants should think of valuation as an option on delivery of metallization capacity (Saskatchewan SRC upgrades and Tooele operations) plus early-offtake monetization rather than a typical industrial multiple multiple.

Catalysts to watch (2–5)

• 06/26/2026 - Completion and deployment of proceeds from the $100M private placement; conference call or 8-K detail on allocation and timelines.
• Tooele Army Base program milestones - design/notice to proceed or financing milestones tied to the conditional selection, and an early construction start window (targeted initial operating capability noted for 2028 in the announcement).
• Saskatchewan Research Council upgrade progress and commercial-scale metallization delivery expected by early 2027 per company commentary; milestone-based operational updates will directly de-risk revenue timing.
• First commercial sales or binding offtake monetization (Tanbreez 15-year offtake allocation for 15% of Phase 1) — any shipment orders or purchase orders will be a material re-rating catalyst.

Trade plan (actionable)

This is a tactical, catalyst-driven long designed to capture re-rating as operations transition toward commercial output. I size this trade as a swing position and recommend a clear stop to protect capital in case milestones slip.

Why these levels? The entry mirrors the current market price and the company’s recent private-placement pricing ($14.25) - buying near $14.66 captures immediate upside as market digests financing and Army selection details. The $12.50 stop sits below recent intraday support and allows for short-term volatility while protecting downside if the financing or early operational signals sour. The $22.00 target is a measured move toward the middle of the prior trading range and reflects a partial re-rating as early sales or firm construction/operational dates are announced; the 52-week high remains $26.90 and could be revisited if execution surprises to the upside.

Risks and counterarguments

• Execution risk: Metallization, heavy-rare-earth refining and magnet manufacturing are technically complex. Missing SRC upgrade deadlines or delays at Tooele would push revenue timelines into 2028 or later and materially compress value.
• Funding and dilution: The $100M placement reduces immediate cash risk, but further capital may be required to scale manufacturing. Future raises could dilute existing shareholders; the company already issued 7,017,540 shares at $14.25 on 06/26/2026.
• Pre-revenue valuation risk (counterargument): The current market cap (~$897M) prices in significant success. If the market decides the timeline or addressable contract size is smaller than assumed, downside could be rapid — this is a common outcome for pre-revenue industrial stories priced for perfection.
• Defense-contract conditionality and regulatory risk: The Tooele award is conditional and uses an Enhanced Use Lease structure; contractual terms, security clearances or procurement specifications could change, slowing deployment or limiting volumes.
• Market and pricing risk: Prices for non-Chinese heavy rare-earths could reprice lower if supply-side responses emerge or if intermediate substitutes reduce demand for dysprosium/terbium at the expected premium.
• Short-interest and market dynamics: Short interest has climbed (settlement 06/15/2026 showed ~3.24M shares short) and short-volume was elevated on 06/26/2026 (~1,040,746 shorted of ~1,505,886 total volume). That can create volatile intraday moves and sudden squeezes in either direction.

Counterargument summarized: The stock may already embody the best-case path to revenue and defense contract monetization. If REalloys fails to hit near-term operational milestones or requires materially more capital, the correction could be steep.

What would change my mind

I’d turn neutral or bearish if the company: (a) publicly misses key SRC or Tooele milestones, (b) discloses material further dilution or inability to secure project financing on acceptable terms, (c) loses exclusivity or priority on identified offtake supply streams (e.g., Tanbreez allocation), or (d) if defense procurement guidance shifts and the January 2027 effective demand window is softened materially. Conversely, I’d add to the position on evidence of first commercial shipments, binding customer purchase orders, or published initial sales with positive gross margins.

Final take

REalloys is a classic binary, catalyst-driven trade: the company has taken concrete steps to derisk funding (closed $100M placement on 06/26/2026) and gained conditional selection from the U.S. Army (06/25/2026) to operate critical processing at Tooele. Those items materially improve the probability of near-term delivery compared with many peers. For traders who can manage the high-volatility profile, a mid-term long from $14.66 with a $12.50 stop and a $22.00 target is a reasonable way to capture upside while limiting downside exposure. Size positions modestly and treat the trade as a milestone play: add if the company confirms construction starts and first-of-a-kind metallization is delivered; exit hard if funding or execution questions re-emerge.

Key monitoring points over the next 45 trading days: SRC upgrade progress announcements, any Tooele program deliverables or financing confirmations, and management commentary on use of proceeds from the $100M placement.